Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Endra Life Sciences Inc (NQ: NDRA )

5.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Endra Life Sciences Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's trading, 123 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences: Q2 Earnings Insights
  ENDRA Life Sciences (NASDAQ:NDRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 127 companies set new 52-week lows. 
Via Benzinga
ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 64 companies achieved new lows for the year. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... 
Via Benzinga
ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion. 
Via Benzinga
ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Preview: ENDRA Life Sciences Earnings
  ENDRA Life Sciences (NASDAQ:NDRA) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. 
Via Benzinga
ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System
From ENDRA Life Sciences
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.